KRAS and colorectal carcinoma: NGS-based profiling of the tumor genome identified a single nonsynonymous mutation among the many genes noted for recurrent mutations in CRC (e.g., KRAS, NRAS, BRAF, PIK3CA) and a striking focal amplification of the FGFR2 gene.